Steris' second-quarter constant-currency organic revenue grew 8% year over year. Adjusted EPS grew 13%, excluding tariff refunds. Management maintained full-year guidance for 6%-7% revenue growth but raised its adjusted EPS outlook to $11.35-$11.55 from $11.10-$11.30, including $0.18 of refunds.
Steris’ technological leadership in applied sterilization technologies, or AST, could attract new customers that lack the capacity to navigate regulatory challenges.
Steris’ frequent acquisitions may not always achieve promised synergies, especially for businesses operating in niche verticals like dental or renal.
Metric | STE | GETI B | MDT |
|---|---|---|---|
Price/Earnings (Normalized) | 22.40 | 23.39 | 17.95 |
Price/Book Value | 3.43 | 2.31 | 2.59 |
Price/Sales | 4.08 | 2.19 | 3.49 |
Price/Cash Flow | 18.53 | 14.24 | 14.58 |
Metric | STE | GETI B | MDT |
|---|---|---|---|
Quick Ratio | 1.27 | 0.72 | 1.29 |
Current Ratio | 2.05 | 1.25 | 2.07 |
Interest Coverage | 20.53 | 7.91 | 10.12 |
Metric | STE | GETI B | MDT |
|---|---|---|---|
Return on Assets (Normalized) | 10.05% | 6.11% | 8.31% |
Return on Equity (Normalized) | 14.93% | 11.50% | 15.59% |
Return on Invested Capital (Normalized) | 11.94% | 9.40% | 10.57% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|Yh&@vvd | LOCK|?F<Z | $189B | |||
| Medtronic PLC MDT | LOCK|D$BG>?$ | LOCK|TTkGn | $130B | |||
| Stryker Corp SYK | LOCK|MtzH>&z | LOCK|Tz | $121B | |||
| Boston Scientific Corp BSX | LOCK|xfsvS^! | LOCK|>!wSL | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|@&W!@!H | LOCK|wc^k | $61B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|#V@!xc | LOCK|@>& | $37B | |||
| DexCom Inc DXCM | LOCK|Rwn^^$R | LOCK|NxDLY | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|Y@Y | LOCK|&H | $30B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|@Pw!<bDf | LOCK|<? | $20B |
United States